Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. This open-label, randomised ...

Capsida Biotherapeutics has suspended a recently begun clinical trial of an experimental gene therapy after the first participant in the study died following treatment. Capsida disclosed the death in ...

Copyright 2025 The Associated Press. All Rights Reserved. Copyright 2025 The Associated Press. All Rights Reserved. Brooklyn Nets center Jason Collins (98) warms up ...

Jackson Roberts is a Newsweek contributor based in Hoboken, NJ. His focus is MLB content. Jackson has been with Newsweek since July of 2025 and previously worked at The Sporting News and MLB Network.

Collins retired in 2014 after a 13-year career in the NBA. The Associated Press Jason Collins currently serves as an ambassador for the NBA. NEW YORK (AP) — Jason Collins, the NBA’s first openly gay ...

The president wants to force people into treatment for substance abuse and mental health issues. In an executive order over the summer, the president called for putting homeless people into, quote, ...

Former NBA center Jason Collins is undergoing treatment for a brain tumor, the NBA said Thursday in a statement. “NBA Ambassador and 13-year veteran Jason Collins is currently undergoing treatment for ...

It was announced Thursday morning that former NBA player and league ambassador Jason Collins is undergoing treatment for a brain tumor. A statement was presented by the NBA on behalf of Collins and ...

Jason Collins, who played 13 years in the NBA for six different teams, is undergoing treatment for a brain tumor, according to a statement released Thursday, September 11, on behalf of his family.

Former NBA center Jason Collins is undergoing treatment for a brain tumor, his family announced through a statement from the NBA. "NBA Ambassador and 13-year NBA veteran Jason Collins is currently ...

Capsida has yet to disclose the exact cause of death. The patient had received the gene therapy CAP-002 for a type of epilepsy. A patient has died after being treated with Capsida Biotherapeutics’ ...

The US Food and Drug Administration has approved Johnson & Johnson’s drug delivery system for a type of bladder cancer, offering a potential surgery-free option for patients. The drug release system, ...